Liver transplantation for the treatment of acute hepatic failure induced by MDMA: a systematic review
Aristotle University of Thessaloniki · 01.01.2023
DOI: 10.26262/heal.auth.ir.353547 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Aristotle University of Thessaloniki, erschienen am 01.01.2023. Verfasst von Stavros Neiros.
Abstract (Originalsprache)
The aim of the present thesis was the study of the effectiveness of liver transplantation as therapeutic option for patients with acute liver failure after MDMA ingestion. For this reason, we conducted a systematic review by following PRISMA reporting guidelines. PubMed, Scopus and Cochrane Central Register of Controlled Trials (CENTRAL) databases were used for all searches from inception to the end of December 2022 supplemented by scanning through studies’ references. The primary endpoint was survival. The included studies were published in English language. Our study underlined the lack of reliable and accurate data on the choice of liver transplantation as a therapeutic option in MDMA induced fulminant hepatic failure. Our recommendation is the creation of an international database for MDMA acute liver failure in order to establish more precise guidelines for this category of patients and consequently have better health outcomes.
Schlagwörter
Zitieren
APA
Neiros, S. (2023). Liver transplantation for the treatment of acute hepatic failure induced by MDMA: a systematic review. Aristotle University of Thessaloniki. https://doi.org/10.26262/heal.auth.ir.353547
Vancouver
Neiros S. Liver transplantation for the treatment of acute hepatic failure induced by MDMA: a systematic review. Aristotle University of Thessaloniki. 2023. doi:10.26262/heal.auth.ir.353547
BibTeX
@article{Neiros2023,
author = {Neiros, Stavros},
title = {Liver transplantation for the treatment of acute hepatic failure induced by MDMA: a systematic review},
journal = {Aristotle University of Thessaloniki},
year = {2023},
doi = {10.26262/heal.auth.ir.353547}
}
EUVIMED